Unfortunately the availability of only CBD isolate medically is a direct consequence of the 1920’s prohibition campaign that outlawed cannabis medications, despite the fact that prior to prohibition cannabis was listed in the United States pharmacopeia as a valuable medication in the treatment of over 100 separate medical conditions. It is still illegal to market THC in cannabis medications despite its known efficacy.
A study published by David Cheng, Postdoctoral Scientist, Neuroscience Research, University of New South Wales, NSW, Australia, says that CBD has a potential as a preventive measure against symptoms of Alzheimer’s. This presents yet another exciting development for medical researchers, given the persistent challenges to finding effective solutions for this condition.
×